Home › Free Stock Grades › IOVA
Iovance Biotherapeutics, Inc. (IOVA) Stock Grade
IOVA · Healthcare
C
Market Cap
$4.9B
P/E Ratio
—
Revenue Growth (YoY)
+60.6%
Net Margin
-148.4%
Return on Equity
—
Dividend Yield
None
About Iovance Biotherapeutics, Inc.'s fundamentals
Iovance Biotherapeutics is a biotechnology company with a market capitalization of $4.9 billion that is experiencing strong revenue growth of 60.6% year-over-year, suggesting expanding commercial traction. However, the company is currently unprofitable, with a net margin of -148.4% and a reported net loss in its latest annual statement, indicating it is investing heavily in growth and operations while not yet achieving profitability. The company does not pay a dividend, which is typical for early-stage biotech firms prioritizing reinvestment and development.